Rabies viruses (RABVs) are non-segmented, negativestranded RNA viruses that belong to the genus Lyssavirus in the family Rhabdoviridae. The RABV genome encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G) and large protein (L). The G protein is the only viral transmembrane protein exposed on the surfaces of viral particles and it is responsible for the infection of host cells (Wunner, 2007) .
RABV is the causative agent of rabies, which is fatal encephalitis in mammals. RABVs are generally classified into two categories: street viruses (field isolates) and fixed viruses (laboratory adapted strains). Fixed viruses are established by the repeated passaging of street viruses in animal brains, tissues and/or cultured cells. Recently, using a street virus strain 1088, which was derived from a rabid woodchuck in the USA, we demonstrated that an additional N-glycosylation at Asn 194 in the G protein was related to enhanced virus production in mouse neuroblastoma NA cells and attenuation in mice (Yamada et al., 2012) . We also mentioned that most street virus G proteins had one (at Asn 319 ) or two sequons (at Asn 37 and Asn 319 ), while fixed virus G proteins had additional sequon(s) at positions 158, 204 or 247. Therefore, it is likely that these additional sequons will also be related to enhanced virus production and the attenuation of pathogenicity, although this has never been tested.
Previously, we constructed plasmids encoding the wildtype (WT) 1088 G protein that contained two sequons at Asn 37 and Asn 319 , or encoding an N-glycan addition mutant with a third sequon at Asn 194 next to the R196S mutation ( Fig. 1a) (Yamada et al., 2012) . In the current study, we generated single sequon-addition mutants, i.e. K158N, S204N and D247N, using a QuikChange II sitedirected mutagenesis kit (Stratagene) (Fig. 1a) . We also generated two sequon-deletion mutants, N37S and N319Q. Based on previous reports, we introduced an NAQ mutation to retain the polarity and size of the amino acid chain (Ito et al., 2007a, b; Kayser et al., 2011; Somnuke et al., 2011; Zhou & Tsai, 2009 ). An N37S mutation is found in several street RABV strains (i.e. GenBank accession numbers EU293116, EU311738 and AY705373).
To determine the glycosylation status of the mutants, each plasmid was transfected into NA cells using TransITNeural reagent (Mirus) and incubated in the presence or absence of tunicamycin (Sigma-Aldrich). G proteins in the transfected cells were detected by Western blotting using anti-G mAb 15-13 (Luo et al., 1997) , as described previously (Yamada et al., 2012) . As shown in Fig. 1(b) , an additional N-glycan was detected in the K158N, R196S and D247N mutants, but its detection was inefficient in S204N. By contrast, the N37S band had a similar mobility to the main WT band, whereas the mobility of the main N319Q band was similar to that of G proteins treated with tunicamycin, indicating that the sequon at Asn 37 was inefficiently core-glycosylated. In addition, Asn 37 was weakly glycosylated in WT and N319Q.
We evaluated the effect of the added N-glycosylation on virus production by performing a pseudotyped virus assay using the G-deficient and EGFP-expressing fixed virus strain RC-HL (RABVDG), which was generated by a reverse-genetics system (Ito et al., 2001 (Ito et al., , 2003 . NA cells cultured in a 24-well plate were transfected with each plasmid (0.5 mg well -1 ) and inoculated with RABVDG carrying the RC-HL G protein (m.o.i. of 1) 5 h after transfection. The cells were replenished with 1 ml Eagle's minimal essential medium (EMEM) supplemented with 5 % FCS. The culture supernatant and cells were collected at 24 h post-infection (p.i.). The infectious titres were determined as described previously with slight modifications (Yamada et al., 2012) , i.e. inoculated cells were fixed at 2 days p.i. and single autofluorescent cells were counted using a fluorescent microscope. The titres were expressed as infectious units (IU) ml -1
. As shown in Fig. 2(a) , N-glycosylation addition enhanced virus production. Compared with the WT, the R196S and D247N mutants had a greatly increased viral titre in the supernatant (i.e. 54-and 15-fold increased, respectively), whereas the K158N and S204N mutants only had a slightly increased viral titre (i.e. 3.1-and 2.2-fold increased, respectively). By contrast, the N-glycosylation deletion mutants exhibited reduced virus production. The N319Q mutant produced the same amount of virus as the empty vector. In addition, RABVDG failed to spread at low m.o.i. in NA cells transfected with N319Q or empty vector (Fig. S1 , available in JGV Online). Taken together, the N319Q mutant had extensively lost its ability to produce virus. In contrast, the N37S mutant produced more virus than the empty vector transfection, and the virus spread was observed in the N37S transfection (Fig. S1 ), indicating that the Nglycan at Asn 37 functions to facilitate the production of viral progeny.
Viral proteins in the supernatant and cells were detected using Western blotting with anti-M (Hiramatsu et al., 1992) and anti-G 15-13 mAbs. Cellular b-actin was also detected as a loading control using mAb G043 (Applied Biological Materials Inc.). The protein bands were detected using an ImageQuant LAS 4000mini (GE Healthcare) and signal quantification was performed by densitometric analysis using the ImageQuant TL program (GE Healthcare). We confirmed that the differences in the titres were not due to the G protein expression levels in cells (Fig. 2b) . The viral structural protein (M protein) levels also increased in the supernatant and they were strongly correlated with the viral infectivity titres ( Fig. 2b and c) , indicating that the additional N-glycosylations enhanced the release of virions from infected cells rather than viral infectivity.
We also performed a pseudotyped virus assay in the nonneural cell line L929, which is derived from mouse fibroblasts. L929 cells were cultured in a 24-well plate and transfected with each plasmid (1 mg well -1 ) by using the TransIT-Neural reagent. The cells were then inoculated with RABVDG carrying the RC-HL G protein (m.o.i. of 2) 24 h after transfection. The cells were replenished with 1 ml EMEM supplemented with 5 % FCS. The culture supernatant and cells were collected at 24 h p.i. As shown in Fig. 2(d) , the R196S and D247N mutants clearly facilitated virus production in L929 cells (P,0.05, Tukey's multiple comparisons test). Interestingly, the K158N mutant enhanced virus production in L929 cells to the same degree as the D247N mutant. The differences in the titres were not due to the G protein expression levels in cells (Fig. 2e) .
In order to find out why R196S and D247N greatly enhanced virus production compared with WT, a transmission electron microscopic analysis was conducted because we hypothesized that the additional N-glycan facilitated viral budding from the plasma membrane. However, although viral cytoplasmic inclusion bodies were detected in most RABVDG-infected cells transfected with WT, R196S or D247N, we failed to observe any sites of viral budding from the plasma membrane (Fig. S2a-c) . Although we rarely ).
Addition of N-glycan to RV G enhances virus production observed virus-like particles around the inclusion bodies in the cytoplasm, there were no differences in the appearance frequency between WT, R196S and D247N (Fig. S2e-g ). We obtained similar results using the fixed virus strain ERA (data not shown). Therefore, our failure to detect viral budding from the plasma membrane was probably not due to our use of the complementation system instead of an authentic virus.
Subsequently, we quantified the production of cellassociated viruses. NA cells were transfected with WT, R196S or D247N plasmids and inoculated with RABVDG carrying the RC-HL G protein (m.o.i. of 2) 5 h after transfection. The culture supernatant and cells were collected separately at 24 h p.i. The collected cells were washed and suspended in 1 ml EMEM with 5 % FCS. Then, any cellassociated viruses were collected after three freeze-thaw cycles and removal of cell debris by centrifugation. As shown in Fig. 2(f) , N-glycan additions at Asn 194 or Asn 247 enhanced production of cell-associated viruses and the cell-associated virus titres were highly correlated with the supernatant viral titres.
Mutant G protein-mediated cell fusion at a low pH was tested as described previously (Yamada et al., 2012) . RABV G protein-mediated fusion requires sequential conformational changes in the G protein (Wunner, 2007) . Transfected NA cells were treated with fusion medium (adjusted to pH 5.8) for 30 min at 24 h after transfection. After fixation, the cells were stained with fuchsine solution. As shown in Fig.  3(a) , only the N319Q mutant lost its low pH-dependent cell fusion activity. Furthermore, we performed an immunofluorescence assay to validate protein folding of mutant G proteins. NA cells were transfected with each plasmid and incubated for 24 h. The cells were fixed with 4 % paraformaldehyde and permeabilized using 0.2 % Triton X-100. The fixed cells were treated for 1 h at 37 u C with anti-G mAb 4-12, which recognized a conformational neutralizing epitope of the antigenic site II (Shiota et al., 2009) , or 15-13, which recognized a linear neutralizing epitope containing the amino acid at position 251 (Luo et al., 1997) . The cells were then stained with Alexa Fluor 488-conjugated anti-mouse IgG (Invitrogen). Images were obtained using Biorevo BZ-9000 fluorescent microscope (Keyence). As shown in Fig.  3(b) , only the N319Q mutant failed to react with mAb 4-12, indicating that the correct folding of N319Q was affected. Thus, the Asn 319 N-glycosylation is required for correct folding, which makes it important for the functional expression of the 1088 G protein.
In this study, we clearly demonstrated that addition of an N-glycan to the street RABV G protein enhanced virus production. However, there were some different aspects.
The Asn 158 N-glycan addition was clearly detectable in the 1088 G protein, but it led to only a slight enhancement of virus production in NA cells, whereas this addition clearly promoted virus production in L929 cells. The sequon at Asn 158 was detected in the fixed virus strain HEP-Flury, which was established by serial passaging in chicken eggs. Irie et al. (2002) found that baby hamster kidney (BHK)-21 cell-adapted HEP-Flury lost the sequon at Asn 158 . Therefore, the facilitative effect of the N-glycan at Asn 158 on virus production might be cell-type specific, although the mechanism is unknown.
The sequon at Asn 37 (followed by Leu 38 and Ser
39
) is highly conserved in RABV strains but Asn 37 is not efficiently coreglycosylated (Kasturi et al., 1995; Shakin-Eshleman et al., 1992 , 1996 . The glycosylation efficiency of Asn 37 depends on the amino acid residue at position 38 and large hydrophobic amino acids (Leu and Trp) are not favourable (Shakin-Eshleman et al., 1996) . In this study, we also showed that Asn 37 was not efficiently core-glycosylated in the 1088 G protein, but the sequon at Asn 37 promoted virus production. Thus, we consider that the ambiguous core glycosylation at Asn 37 may be optimized in RABVs that circulate in nature, so the sequon of Asn 37 followed by Leu 38 and Ser 39 is conserved. Moreover, the absence of the sequon at position 37 in some street RABVs derived from bats could also be beneficial to viral circulation in that host.
As found in the fixed RABV strain CVS (Wunner et al., 1985) , the additional sequon at Asn 204 did not act as an efficient core glycosylation signal in the 1088 G protein.
However, the addition facilitated slightly higher virus Addition of N-glycan to RV G enhances virus production production. The CVS strain is highly virulent and it is used as a challenge virus in a vaccine potency test. Therefore, the sequon at Asn 204 might have been selected via a trade-off between adaptation and virulence.
The sequon at Asn 319 is conserved in the G protein of RABVs and other lyssaviruses (Badrane & Tordo, 2001) , indicating that it probably has an important role in the G protein function. Our results showed that an N-glycan at Asn 319 is important for the function of the street RABV G protein. The majority of the N319Q mutant was present in a non-glycosylated form, which probably inhibited its association with chaperon proteins in the endoplasmic reticulum, thereby preventing correct folding (Gaudin, 1997) . However, the importance of the N-glycan at Asn 319 is still uncertain in the fixed RABV G proteins because they have an additional N-glycan that could substitute for the N-glycan at Asn 319 .
The additional N-glycans at Asn 194 or Asn 247 greatly enhanced virus production in the supernatant although the expression levels in cells were similar between WT, R196S and D247N. Therefore, the additional sequons at Asn 247 that are present in several fixed viruses (Yamada et al., 2012) probably have been selected during the adaptation. Furthermore, R196S and D247N clearly promoted production of cell-associated viruses thought to be intracellular viruses, which might be released from cells via a secretory pathway as speculated elsewhere (Wunner, 2007) . If so, there are two possible reasons why N-glycan additions promoted the intracellular virus production. First, the N-glycan addition mutants might mature more efficiently than the WT. Second, the WT G protein might be trapped by a host molecule before or after intracellular viral morphogenesis and the additional N-glycans may interfere with this interaction. Further investigations are needed to test these hypotheses.
The results of our current study explain why a mutation leading to additional N-glycosylation of the G protein has been selected during the adaptation of fixed virus strains. Furthermore, we consider that investigations of the roles of N-glycans during viral propagation are useful and important for the development of effective vaccines and antiviral drugs.
